Immutep dips as safety test for flagship drug IMP761 shows no adverse effects
Immutep Ltd (ASX:IMM) has reported a small-scale conceptual safety test among 49…
Immutep Limited (ASX:IMM)
About Immutep Limited
Key Information
IMM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/12/2024 | Notification of cessation of securities - IMM | 12.73KB | 434 |
| 17/12/2024 | Price Sensitive PS Immutep announces initial safety data from IMP761 phase 1 | 101.88KB | 1.6K |
| 16/12/2024 | Publication Detailing How Human LAG-3 Binds to MHC Class II | 384.45KB | 5.2K |
| 13/12/2024 | Application for quotation of securities - IMM | 15.75KB | 452 |
| 12/12/2024 | Price Sensitive PS Immutep Reports Promising New Data in Head and Neck Cancer | 865.06KB | 11K |
| 10/12/2024 | Change of Director's Interest Notice - L Boyce | 125.62KB | 342 |
| 10/12/2024 | Change of Director's Interest Notice - R Howard | 126.18KB | 293 |
| 10/12/2024 | Change of Director's Interest Notice - F Triebel | 127.82KB | 289 |